Robert W. Piepho
About
In The Last Decade
Robert W. Piepho
29 papers receiving 590 citations
Peers
Comparison fields: 5 of 111
- Cardiology and Cardiovascular Medicine 218
- Psychiatry and Mental health 112
- Molecular Biology 107
- Endocrinology, Diabetes and Metabolism 104
- Physiology 76
Countries citing papers authored by Robert W. Piepho
This map shows the geographic impact of Robert W. Piepho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert W. Piepho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert W. Piepho more than expected).
Fields of papers citing papers by Robert W. Piepho
This network shows the impact of papers produced by Robert W. Piepho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert W. Piepho. The network helps show where Robert W. Piepho may publish in the future.
Co-authorship network of co-authors of Robert W. Piepho
This figure shows the co-authorship network connecting the top 25 collaborators of Robert W. Piepho. A scholar is included among the top collaborators of Robert W. Piepho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert W. Piepho. Robert W. Piepho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 50 | |
| 2 | Comment minimiser les risques associés à un allongement significatif de l’intervalle QTc chez les personnes souffrant de schizophrénie.Recommandations consensuelles du Cardiac safety in schizophrenia group | 1 |
| 3 | 8 | |
| 4 | 7 | |
| 5 | 19 | |
| 6 | 62 | |
| 7 | 2 | |
| 8 | 60 | |
| 9 | 87 | |
| 10 | 19 | |
| 11 | 7 | |
| 12 | 12 | |
| 13 | 12 | |
| 14 | 6 | |
| 15 | Drug interactions with the calcium-entry blockers. | 26 |
| 16 | 6 | |
| 17 | 7 | |
| 18 | 74 | |
| 19 | 34 | |
| 20 | Pharmacists' knowledge and attitudes regarding monitoring the behaviors of children with learning disabilities. | 0 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.